Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Embolic protection devices recalled | COVID-related heart damage & 1-year outcomes | LAAC vs DOACs for AFib
Wednesday, January 12, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

FDA announces recall of nearly 700 embolic protection devices after multiple malfunctions

The device's filter is breaking off during the retrieval process, making it much more difficult to withdraw. 

READ MORE >
Recall | Product recall
Share on Twitter Share on Facebook Share on Linkedin

FDA announces recall of nearly 700 embolic protection devices after multiple malfunctions

Share on Twitter Share on Facebook Share on Linkedin
Recall | Product recall
The device's filter is breaking off during the retrieval process, making it much more difficult to withdraw. 
READ MORE >

1-year outcomes much worse among hospitalized COVID-19 patients with heart damage

"Long COVID" is also much more common among patients who originally presented with signs of myocardial injury.

READ MORE >
COVID-19 coronavirus
Share on Twitter Share on Facebook Share on Linkedin

1-year outcomes much worse among hospitalized COVID-19 patients with heart damage

Share on Twitter Share on Facebook Share on Linkedin
COVID-19 coronavirus
"Long COVID" is also much more common among patients who originally presented with signs of myocardial injury.
READ MORE >

LAAC or DOACs? How treatment strategies for AFib impact long-term outcomes

The new analysis provided an update on data from the PRAGUE-17 trial. 

READ MORE >
Doctor patient
Share on Twitter Share on Facebook Share on Linkedin

LAAC or DOACs? How treatment strategies for AFib impact long-term outcomes

Share on Twitter Share on Facebook Share on Linkedin
Doctor patient
The new analysis provided an update on data from the PRAGUE-17 trial. 
READ MORE >

Clinical study of robotic-assisted cardiology solution reaches conclusion

“Robotics is, in all likelihood, the future of interventional cardiology," one specialist said. Full study results are expected in May.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Clinical study of robotic-assisted cardiology solution reaches conclusion

Share on Twitter Share on Facebook Share on Linkedin
“Robotics is, in all likelihood, the future of interventional cardiology," one specialist said. Full study results are expected in May.
READ MORE >

Survival, reintervention rates for TPVR comparable to surgery

These findings, the authors wrote, should help inform the decision-making process when different treatment options are being considered. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Survival, reintervention rates for TPVR comparable to surgery

Share on Twitter Share on Facebook Share on Linkedin
These findings, the authors wrote, should help inform the decision-making process when different treatment options are being considered. 
READ MORE >

Featured Articles

Just 1 month of DAPT after PCI shows promise, new meta-analysis confirms

Researchers evaluated data from four different studies, sharing their results in the American Journal of Cardiology.

READ MORE >
IVUS guidance during DES implantation boosts long-term outcomes in new study
Share on Twitter Share on Facebook Share on Linkedin

Just 1 month of DAPT after PCI shows promise, new meta-analysis confirms

Share on Twitter Share on Facebook Share on Linkedin
IVUS guidance during DES implantation boosts long-term outcomes in new study
Researchers evaluated data from four different studies, sharing their results in the American Journal of Cardiology.
READ MORE >

Heart specialists highlight importance of COVID-19 vaccination as omicron cases skyrocket

“COVID-19 vaccination and boosters continue to be our No. 1 defense to save lives and protect against COVID-19 infection, severe illness and death,” according to the American Heart Association. 

READ MORE >
Vaccination
Share on Twitter Share on Facebook Share on Linkedin

Heart specialists highlight importance of COVID-19 vaccination as omicron cases skyrocket

Share on Twitter Share on Facebook Share on Linkedin
Vaccination
“COVID-19 vaccination and boosters continue to be our No. 1 defense to save lives and protect against COVID-19 infection, severe illness and death,” according to the American Heart Association. 
READ MORE >

Adults with type 2 diabetes are not taking care of their hearts

A new scientific statement from the American Heart Association explored this issue in great detail.

READ MORE >
people
Share on Twitter Share on Facebook Share on Linkedin

Adults with type 2 diabetes are not taking care of their hearts

Share on Twitter Share on Facebook Share on Linkedin
people
A new scientific statement from the American Heart Association explored this issue in great detail.
READ MORE >

Self-expanding TAVR system gains approval for high-risk patients in China

The National Medical Products Administration reviewed data from more than 32,000 patients to make its decision.

READ MORE >
approved approval safe
Share on Twitter Share on Facebook Share on Linkedin

Self-expanding TAVR system gains approval for high-risk patients in China

Share on Twitter Share on Facebook Share on Linkedin
approved approval safe
The National Medical Products Administration reviewed data from more than 32,000 patients to make its decision.
READ MORE >

Personal ECG solution approved by NICE for detecting signs of AFib

The solution was designed to provide high-quality ECG readings without patients needing to leave the comfort of home. 

READ MORE >
Electrocardiograms analyzed by AI can offer information about mortality risk.
Share on Twitter Share on Facebook Share on Linkedin

Personal ECG solution approved by NICE for detecting signs of AFib

Share on Twitter Share on Facebook Share on Linkedin
Electrocardiograms analyzed by AI can offer information about mortality risk.
The solution was designed to provide high-quality ECG readings without patients needing to leave the comfort of home. 
READ MORE >

In Other News

Insurers will cover at-home COVID-19 tests starting Saturday

Individuals with private insurance or group health plans are entitled to eight free over-the-counter tests each month, the Biden administration announced this week.

READ MORE >
COVID-19 congress coronavirus Washington
Share on Twitter Share on Facebook Share on Linkedin

Insurers will cover at-home COVID-19 tests starting Saturday

Share on Twitter Share on Facebook Share on Linkedin
COVID-19 congress coronavirus Washington
Individuals with private insurance or group health plans are entitled to eight free over-the-counter tests each month, the Biden administration announced this week.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

FDA clears AI imaging tech | A close look at cardioneural ablation | Celebrating top hospitals | New TAVR device performing well
Week in Review: Americans keep poisoning themselves | Device recalled over safety concerns | ACC takes on antiplatelet therapies
AI works behind the scenes | CCTA scan delivers wake-up call | The future of FFR-CT | Subtle heart changes linked to cancer risk
Looking Back: Is coffee bad for the heart? | Procedure kit recalls | Cardiologist gets wake-up call | TAVR policy changes
Compensation still on the rise | Procedure kits recalled | A new definition of heart failure | Cardiologist named AHA president
New antiplatelet recommendations | Heart failure drug recalled | Imaging tech makes US debut | Conavi Medical's good news
Safety concerns lead to new recall | FDA approves surgical device | Parents in jail after obese son's death | A fraud warning

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme